NCT00058253View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

January 31, 2008

Study Completion Date

March 31, 2010

Conditions
Recurrent Prostate CancerStage IV Prostate CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

tanespimycin

Given IV

DRUG

docetaxel

Given IV

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00058253 - Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | Biotech Hunter | Biotech Hunter